Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 925-936 of 4,306
Drug study icon
CompletedNCT02469155

A study to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 60 Years
Countries
United States
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00490516

ACP-104 in Acutely Psychotic Subjects With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Anaheim
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Drug study icon
TerminatedNCT01908192

Adaptive Phase II Study Safety & Efficacy of NaBen®

This study was terminated in the United States and in Taiwan. It focuses on Schizophrenia.

Multiple locations, including Dothan
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 12 Years to 17 Years
Countries
United States, Taiwan
Sponsor
SyneuRx International (Taiwan) Corp
Condition
Schizophrenia
Other study type icon
Active Not RecruitingNCT04951700

Aging and Disease Course: Contributions to Lifespan Neurobiology of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Dallas
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 75 Years
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Condition
Schizophrenia
Drug study icon
CompletedNCT03788759

Alpha-lipoic Acid Adjunctive Therapy in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Fortaleza
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 60 Years
Countries
Brazil
Sponsor
Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara
Condition
Schizophrenia
Drug study icon
CompletedNCT00992407

Long Acting Injectable Risperidone and Oral Risperidone for schizophrenia

This study is completed in South Korea. It is testing long Acting Injectable Risperidone and Oral Risperidone for schizophrenia.

In Ansan
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
South Korea
Sponsor
Janssen Korea, Ltd., Korea
Condition
Schizophrenia
Drug study icon
CompletedNCT00460512

Safety study of Flexibly Dosed Paliperidone Extended Release (ER) in schizophrenia

This study is completed in France, in the United Kingdom, in Switzerland, .... It is testing Flexibly Dosed Paliperidone Extended Release (ER) for schizophrenia.

Multiple locations, including Antwerp
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 18 Years
Countries
France, United Kingdom, Switzerland, ...
Sponsor
Janssen-Cilag International NV
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.